Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 689-986-7 | CAS number: 1742-79-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03 December 2012 to 22 October 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Conducted according to current test guidelines and GLP compliant
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- 2-oxo-1,2-dihydropyridin-1-yl acetate
- EC Number:
- 689-986-7
- Cas Number:
- 1742-79-6
- Molecular formula:
- C7H7NO3
- IUPAC Name:
- 2-oxo-1,2-dihydropyridin-1-yl acetate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Name: Oxypyrion-Acetate
CAS Number: 1742-79-6
Batch number: 11085913
Purity: Not stated
Date of arrival: 20 November 2012
Storage conditions: Refrigerated (2 to 8°C)
Constituent 1
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: reconstructed epidermis
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- The test system was a three-dimensional human skin model, comprising a reconstructed epidermis with a functional stratum corneum supplied by MatTek Corporation. Human keratinocytes were used to construct the epithelium. Multiple layers of viable epithelial cells were present under a functional stratum corneum. The stratum corneum was multi-layered with the necessary lipid profile to produce a functional barrier. The containment properties of the model prevented the passage of material around the stratum corneum to the viable model tissue. The skin model was supplied free of contamination with bacteria, mycoplasma and fungi.
EpiDermTM SIT (EPI-200) tissues were kept in their packaging at room temperature in a microbiological safety cabinet until the next step. The tissues were set up the day prior to treatment by placing each tissue onto 0.9 mL pre-warmed maintenance medium (supplied with the EpiDermTM SIT (EPI-200) tissues) in 6-well plates and incubating at 37°C.
The test was performed on a total of three tissues per test item, negative and positive control. Immediately prior to treatment initiation, the media under the tissues was replaced with 0.9 mL of pre-warmed assay medium (supplied with the EpiDermTM SIT (EPI-200) tissues).
Three tissues were treated by application of 25 mg of test item (with the tissue moistened with 25 µL sterile PBS) onto the surface of the tissues. The tissues were incubated at 37 ± 1°C, 5 ± 1% CO2 for a 35 ± 1 minute period. The plates were then removed from the incubator and placed into a sterile hood until the 60 ± 1 minute treatment period was complete for each tissue.
This procedure was repeated using a group of three tissues treated with 30 µL of the negative control and a further group of three tissues treated with 30 µL of the positive control.
Following treatment, substances were removed by washing the tissues. The tissues were then placed on the appropriate medium and incubated for 42 hours.
At the end of the 42-hour incubation period, tissue viability was assessed by MTT assay.
Once all tissues were rinsed, they were transferred to wells containing 300 µL of the positive control.
FollowiL of 1 mg/mL MTT-medium and were incubated for 3 hours (37°C, 5% CO2). The protocol specified that at the end of the incubation period, the tissues would be removed from the MTT solution and any resultant colour formed in the tissues by the MTT assay would be extracted. However, in a deviation from protocol, the tissues were not removed from the MTT solution and 2 mL of isopropanol was added to the tissues whilst still in the MTT solution.
It was considered that this deviation may have impacted on the integrity or outcome of the study, therefore the test procedure was therefore repeated using fresh tissues, with the extraction procedure following the requirements of the protocol.
In the repeat test, at the end of the 42-hour incubation period all tissues were rinsed, transferred to wells containing 300 µL of the positive control.
FollowiL of 1 mg/mL MTT-medium and incubated for 3 hours (37°C, 5% CO2). The tissues were then removed from the MTT solution and placed in clean wells. Any resultant colour was extracted by flooding the tissue with 2 mL isopropanol and shaking for a further two hours at room temperature.
Upon completion of the extraction, each tissue was pierced using a hypodermic needle so that the extract could run through the tissue. Once drained, the tissue was discarded and the extract mixed by shaking for two hours. Two x 200 µL of the positive control.
FollowiL aliquots of each resultant extract were placed into a 96-well plate for spectrophotometric determination of optical density at 570 nm using extraction solution as a blank. Tissue viability was calculated for each tissue as a percentage of the mean of the negative control tissues. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- The test was performed on a total of three tissues per test item, negative and positive control. Immediately prior to treatment initiation, the media under the tissues was replaced with 0.9 mL of pre-warmed assay medium (supplied with the EpiDermTM SIT (EPI-200) tissues).
Three tissues were treated by application of 25 mg of test item (with the tissue moistened with 25 µL sterile PBS) onto the surface of the tissues. - Duration of treatment / exposure:
- The tissues were incubated at 37 ± 1°C, 5 ± 1% CO2 for a 35 ± 1 minute period. The plates were then removed from the incubator and placed into a sterile hood until the 60 ± 1 minute treatment period was complete for each tissue. Following treatment, substances were removed by washing the tissues.
- Duration of post-treatment incubation (if applicable):
- The tissues were then placed on the appropriate medium and incubated for 42 hours.
- Number of replicates:
- three
Test animals
- Species:
- other:
- Strain:
- other:
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 1
- Value:
- 5.8
- Negative controls validity:
- valid
- Remarks:
- 100% viability
- Positive controls validity:
- valid
- Remarks:
- 3.9% viability
- Remarks on result:
- positive indication of irritation
- Other effects / acceptance of results:
- The group mean viability for the test item was 5.8%.
The group mean viability for the negative control was 100%.
The group mean viability for the positive control was 3.9%.
Any other information on results incl. tables
Test substance |
OD570 |
Mean |
Corrected mean |
% relative survival |
Mean |
SD |
CV |
|
Negative |
1.735 |
1.740 |
1.738 |
1.738 |
116.8 |
100.0 |
18.077 |
18.077 |
Negative |
1.203 |
1.204 |
1.203 |
1.203 |
80.9 |
|||
Negative |
1.476 |
1.568 |
1.522 |
1.522 |
102.3 |
|||
Test item |
0.077 |
0.095 |
0.086 |
0.086 |
5.8 |
5.8 |
0.400 |
6.921 |
Test item |
0.091 |
0.093 |
0.092 |
0.092 |
6.2 |
|||
Test item |
0.078 |
0.082 |
0.080 |
0.080 |
5.4 |
|||
Positive |
0.049 |
0.053 |
0.051 |
0.051 |
3.4 |
3.9 |
0.411 |
10.588 |
Positive |
0.064 |
0.062 |
0.063 |
0.063 |
4.2 |
|||
Positive |
0.061 |
0.058 |
0.059 |
0.059 |
4.0 |
|||
Blank |
0.000 |
0.000 |
|
|
|
|
|
|
Applicant's summary and conclusion
- Conclusions:
- The test item, Oxypyrion-Acetate, was considered to be irritant (GHS category 2) to the in vitro skin model EpiDerm SIT (EPI-200).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.